Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Lingen

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 24, 2020
Making oral pathology lemonade from COVID-19 lemonsMark W Lingen
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 27, 2018
Triple O Content Innovations and New Section EditorsMark W Lingen
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|July 15, 2009
Point of care salivary diagnostics for systemic disease screening: if someone builds it, will dentistry come?Mark W Lingen
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|May 22, 2021
The journal welcomes new OMS section editorMark W Lingen
Cancer Prevention Research (Philadelphia, Pa.)|August 23, 2012
Validation of LOH profiles for assessing oral cancer riskMark W Lingen, Eva Szabo
Head and Neck Pathology|May 15, 2023
Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Oral Cavity Dysplasia: Why Does Histologic Grading Continue to be Contentious?Rachelle Wolk, Mark W Lingen
Seminars in Oncology|December 16, 2004
Head and neck cancer: the pursuit of molecular diagnostic markersRifat Hasina, Mark W Lingen
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 26, 2021
Why Doesn't Medicare Treat All Diagnostic Tests Equally?Mark W Lingen, John R Kalmar
Neoplasia (New York, N.Y.)|January 12, 2013
The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7Tanmayi P Mankame, Mark W Lingen
Seminars in Oncology|December 16, 2004
Update in head and neck oncologyEverett E Vokes, Mark W Lingen
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 24, 2020
Making oral pathology lemonade from COVID-19 lemonsMark W Lingen
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 27, 2018
Triple O Content Innovations and New Section EditorsMark W Lingen
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|July 15, 2009
Point of care salivary diagnostics for systemic disease screening: if someone builds it, will dentistry come?Mark W Lingen
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|May 22, 2021
The journal welcomes new OMS section editorMark W Lingen
Cancer Prevention Research (Philadelphia, Pa.)|August 23, 2012
Validation of LOH profiles for assessing oral cancer riskMark W Lingen, Eva Szabo
Head and Neck Pathology|May 15, 2023
Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Oral Cavity Dysplasia: Why Does Histologic Grading Continue to be Contentious?Rachelle Wolk, Mark W Lingen
Seminars in Oncology|December 16, 2004
Head and neck cancer: the pursuit of molecular diagnostic markersRifat Hasina, Mark W Lingen
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|November 26, 2021
Why Doesn't Medicare Treat All Diagnostic Tests Equally?Mark W Lingen, John R Kalmar
Neoplasia (New York, N.Y.)|January 12, 2013
The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7Tanmayi P Mankame, Mark W Lingen
Seminars in Oncology|December 16, 2004
Update in head and neck oncologyEverett E Vokes, Mark W Lingen
Pageof 16